Overview


According to FutureWise analysis the market for Europe Organ Preservation in 2023 is US$ 85.27 million, and is expected to reach US$ 129.8 million by 2031 at a CAGR of 5.80%.

Organ preservation refers to the process of keeping an organ in a viable state until it can be transplanted into a recipient. This is done by cooling the organ to slow down metabolic processes, and using a preservation solution to prevent tissue damage. The goal of organ preservation is to maintain the organ's function and viability, allowing for successful transplantation. The ability to transport organs across large distances and shorten the time between procurement and transplantation make organ preservation a crucial component of the organ transplantation procedure.

Organ disease is a significant public health concern, and organ transplantation is a potentially life-saving procedure. Chronic kidney disease (CKD) causes damage to the kidneys, which may make them less effective in removing waste products from the blood over time. For example, according to information made public on World kidney Day, a joint project of the International Federation of Kidney Foundations and the International Society of Nephrology, renal disease afflicted almost 850 million people worldwide in 2020. Estimates indicate that one in ten persons suffer from chronic kidney disease. By 2040, it is expected that CKD will account for the fifth-highest proportion of all causes of years lost to mortality worldwide. Therefore, a rise in organ illnesses may cause organ failure, necessitating transplantation and, consequently, a rise in need for organ preservation.

FutureWise Market Research has published a report that provides an insightful analysis of Europe Organ Preservation Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that the Europe Organ Preservation Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Bristol-myers Squibb
  • Xvivo Perfusion AB
  • Paragonix Technologies
  • Franz Kohler Chemie Gmbh
  • Biolife Solutions Inc.
  • Claris Lifesciences Limited
  • Lifeline Scientific
  • Tolerotech Inc.
  • 21st Century Medicine
  • Cryolife Inc.

Recent developments by key players in Organ Preservation Market:

The LIVERguardtm donor liver preservation system was introduced in October 2021 by Paragonix Technologies, the industry's top supplier of systems for preserving and transporting donor organs, for use in both clinical and commercial settings.

The major factor propelling the growth of the organ preservation market in the aforementioned forecast period is the rising incidences of organ failures occurring in European countries amid rapid geriatric population growth, along with the various regional authorities providing favourable regulations across Europe. Additionally, factors like organizing initiatives and developing awareness campaigns to boost the number of organ donors and transplant surgeries also accelerate the market's overall growth. According to estimates, the overall growth of the market will quicken in the projected period due to the rising prevalence of multi-organ failure and significant advancements in the nation's healthcare system. The market's growth is hampered by the high costs connected with organ transplantation, which limits the procedure being opted further resulting in a narrower consumer base.

By Solution

  • University of Wisconsin (UW)
  • Custodial HTK
  • Perfadex
  • Others (Celsior & Euro-Collins)

By Technique

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

By Organ Type

  • Kidneys
  • Liver
  • Lung
  • Heart
  • Others (Intestine & Pancreas)

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various countries listed above. A deep-down analysis of countries will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

The market is fueled by factors including expanding government, advanced goods and technology, and an increase in chronic ailments in the region. Germany is an appealing market because of its steady expansion and advanced approach to the healthcare industry. Federal Statistical Office estimates that Germany spent 460.03 billion US dollars on healthcare in 2019. Globally, there is still a great need for highly creative technology, as well as for therapeutic, diagnostic and minimally invasive equipment. The organ donation system has benefited from several government initiatives that have increased funds, supported laws, and built out infrastructure in this region.


  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth
  • To provide with an exhaustive analysis on the Organ Preservation Market By Solution, By Technique, By Organ Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Organ Preservation Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Organ Preservation Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Organ Preservation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Organ Preservation Market, By Solution Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. University of Wisconsin (UW)
        2. Custodial HTK
        3. Perfadex
        4. Others (Celsior & Euro-Collins)

  • 8.   Organ Preservation Market, By Technique Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Static Cold Storage
        2. Hypothermic Machine Perfusion
        3. Normothermic Machine Perfusion

  • 9.   Organ Preservation Market, By Organ Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Kidneys
        2. Liver
        3. Lung
        4. Heart
        5. Others (Intestine & Pancreas)

  • 10.   North America Organ Preservation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Organ Preservation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Organ Preservation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Organ Preservation Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bristol-myers Squibb
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Xvivo Perfusion AB
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Paragonix Technologies
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Franz Kohler Chemie Gmbh.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Biolife Solutions Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Claris Lifesciences Limited
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Lifeline Scientific
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Tolerotech Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. 21st Century Medicine
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Cryolife Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients